Skip to content

Cartico steroid injection combined with Millâ??s manipulation in Lateral epicondylitis

MRI and Ultra sound analysis of Cartico steroid injection combined with Millâ??s manipulation in Lateral epicondylitis - A prospective, randomised, double - blinded, placebo controlled trial.

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025135
Enrollment
60
Registered
2020-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M259- Joint disorder, unspecified

Interventions

Intervention1: Carticosteroid injection and Millâ??s manipulation: A routine clinical examination will be conducted by the treating medical practitioner prior to injection of 1 ml Triamcinolone Aceton

Sponsors

Prince Sattam Bin Abdulaziz University Al Kharj Saudi Arabia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18 â?? 60 years with pain over lateral humeral epicondyle, unilateral elbow pain for more than 2 months with pain intensity in VAS scale between 4 and 8 mm and willing to participate for the treatment and further follow up program will be included

Exclusion criteria

Exclusion criteria: Participants with prior steroid injection therapy, associated neck or arm pain, severe musculoskeletal, neural, somatic and psychiatric conditions, waiting for surgery, having alcohol or drug abuse, involving in other weight training programs were excluded from the study. Participants with other soft tissue injuries, fracture at the limbs, deformities were also excluded from the study.

Design outcomes

Primary

MeasureTime frame
1. MRI analysis - Common extensor tendon injury 2. Ultra sound analysi - Common extensor tendon injury 3. Pain intensity â?? VAS 4.Functional disability - Patient rated tennis elbow evaluation 5.Hand grip â?? Hand dynamometer Timepoint: Baseline, after 4 weeks, 8 weeks and 6 months

Secondary

MeasureTime frame
1. Patient perception â?? Global impression of change 2. Kinesiophobia â?? Tampa scale 3. Depression â?? Hospital anxiety and depression scale 4. Quality of life â?? Euro Qol EQ-5D Timepoint: Baseline, after 4 weeks, 8 weeks and 6 months

Countries

Saudi Arabia

Contacts

Public ContactGopal Nambi

Prince Sattam Bin Adul Aziz University, Saudi Arabia.

physio_gopal@rediffmail.com0501878382

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 10, 2026